Wealthcare Advisory Partners’s Melinta Therapeutics, Inc. Common Stock MLNT Stock Holding History

Wealthcare Advisory Partners’s Portfolio MLNT Stock Details MLNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-65	Closed	–	–	1634
2019 Q4	$0	Hold	65	–	–	﹤0.01%	1466
2019 Q3	$0	Hold	65	–	–	﹤0.01%	1448
2019 Q2	$0	Hold	65	–	–	﹤0.01%	1384
2019 Q1	$0	Hold	65	–	–	﹤0.01%	1309
2018 Q4	$0	Hold	65	–	–	﹤0.01%	1313
2018 Q3	$1K	Hold	65	–	–	﹤0.01%	1216
2018 Q2	$2K	Buy	+65	New	+$2.34K	﹤0.01%	1152

Wealthcare Advisory Partners's MLNT Position: Q1 2020 in Review

Wealthcare Advisory Partners sold out of Melinta Therapeutics, Inc. Common Stock (MLNT) in Q1 2020, closing a stake of 65 shares.

Wealthcare Advisory Partners first reported a position in MLNT in Q2 2018 and held it in 7 quarters. The position peaked at $2K in Q2 2018. 2 funds tracked by Wall St. Rank hold MLNT as of Q1 2020.

Wealthcare Advisory Partners reported no remaining Melinta Therapeutics, Inc. Common Stock position as of Q1 2020 after selling out during the quarter.
Wealthcare Advisory Partners sold 65 Melinta Therapeutics, Inc. Common Stock shares in Q1 2020.
Wealthcare Advisory Partners first reported a position in Melinta Therapeutics, Inc. Common Stock in Q2 2018 and held it in 7 quarters.
Wealthcare Advisory Partners's Melinta Therapeutics, Inc. Common Stock position peaked at $2K in Q2 2018.
2 funds tracked by Wall St. Rank held Melinta Therapeutics, Inc. Common Stock as of Q1 2020.

Based on Wealthcare Advisory Partners's 13F filing for Q1 2020, filed 29 Apr 2020.